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Objective: The objective of this study was to characterize the genetic abnormalities in two fetuses with
congenital anomalies in prenatal screening.
Materials and methods: The mother of Fetus 1 was 26 years old and had a second trimester serum
screening that indicated the fetus was at low risk. The prenatal ultrasound and magnetic resonance
imaging (MRI) at 28 weeks of gestation showed mild ventriculomegaly, microcephaly, and agenesis of
the corpus callosum. The mother of Fetus 2 was 25 years old and also had a second trimester serum
screening that indicated the fetus was at low risk. The prenatal ultrasound at 32 weeks of gestation
showed the presence of hyperechogenic and enlarged kidneys with multicystic renal dysplasia bilaterally
and a persistent left superior vena cava (PLSVC). Both pregnant women underwent cord blood samplings
because of the abnormal imaging results. Karyotype analysis revealed normal results in the two fetuses.
Chromosome microarray analysis (CMA) was then performed to provide genetic analysis of the cord
blood and parental blood samples. Ultimately, the pregnancies were both terminated.
Results: CMA detected a 1.56-Mb duplication at 17q12 in Fetus 1 and a 1.93-Mb deletion of 17q12 in Fetus
2. Both the duplicated and deleted regions included the HNF1B and LHX1 genes. Neither the duplication
nor deletion was inherited from the parents.
Conclusion: This study is the ﬁrst to report the prenatal diagnosis of a 17q12 duplication syndrome. Our
results further conﬁrmed that genes in this region, including HNF1B and LHX1, are essential for normal
brain and kidney development, and also indicated some genes that may be associated with the car-
diovascular abnormality. Combined with imaging examination, the use of CMA will improve the diag-
nosis of submicroscopic chromosomal aberrations in fetuses with congenital anomalies.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Chromosome 17q12 deletions and duplications have been
established to be associated with a wide range of clinical pheno-
types with considerable variability in expressivity. Generally, a
deletion of 17q12 is associated with renal cyst and diabetes syn-
drome [1e3], developmental delay [2e4], autism and schizo-
phrenia [4e6], seizures [2,3], and less common phenotypes
containing dysmorphic features [4,6], transient neonatal hyper-
calcemia [4], Mullerian aplasia [7,8], and congenital diaphragmatic
hernia [9]. A duplication of 17q12 could result in developmentaliagnostic Center, Guangzhou
9 Jinsui Road, Guangzhou,
bstetrics & Gynecology. Publisheddelay [2,3,10,11], structural abnormalities of the brain [2,3,10],
cognitive impairment and behavioral abnormalities [3], epilepsy
[2,10], and less common phenotypes including esophageal atresia
[3,12], eye anomalies, cleft soft palate, sex reversal, cardiac defects,
and Peters' anomaly [11]. Recently, Hendrix et al [9] and Chen et al
[13] reported the prenatal diagnosis of 17q12 deletion syndrome in
two fetuses. Here, we present our study on the prenatal diagnosis of
a 17q12 duplication and deletion in two fetuses with ultrasound
ﬁndings by chromosome microarray analysis (CMA).Materials and methods
Clinical description
Themother (G1P0A0) of Fetus 1was 26 years old and her second
trimester serum screening indicated that the fetus was at low risk.by Elsevier Taiwan LLC. All rights reserved.
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R. Li et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 579e582580The prenatal ultrasound at 28 weeks of gestation showed that the
width of the bilateral lateral ventricles was 10 mm, the biparietal
diameter was 59 mm, and the pericallosal artery took an abnormal
course. Cardiac and urogenital systemswere normal. To conﬁrm the
abnormality of brain structure, magnetic resonance imaging (MRI)
was then performed and revealed that the width of the bilateral
lateral ventricles was 12 mm, the biparietal diameter was 63.4 mm
(the reference value at the 28th week was 72.5 ± 5.1 mm), and the
corpus callosum was faintly visible. The mother had no signiﬁcant
medical, surgical, or family history. She received genetic counseling
on the abnormal ultrasound and MRI ﬁndings and underwent cord
blood sampling at the prenatal diagnostic center. The karyotype
analysis revealed a normal female (46, XX).
Themother (G1P0A0) of Fetus 2was 25 years old and her second
trimester serum screening indicated that the fetus was at low risk.
The prenatal ultrasound at 32 weeks of gestation showed the
presence of persistent left superior vena cava (PLSVC), hyper-
echogenic and enlarged kidneys (right kidney measured
38 mm  28 mm, left kidney measured 39 mm  29 mm) with
multicystic renal dysplasia bilaterally, and polyhydramnios (amni-
otic ﬂuid index was 286 mm). The brain structure was normal. The
mother had no signiﬁcant medical, surgical, or family history. She
received counseling and decided to undergo cord blood sampling.
The karyotype analysis showed a normal male (46, XY).
CMA
Because the routine chromosome analysis revealed normal
karyotypes, a CytoScan 750K array (Affymetrix Inc, Santa Clara, CA,
USA)was used for CMA for each of the two fetuses. Parental blood
samples from each set of parents were also obtained for the
microarray analysis. The procedures for DNA digestion, ampliﬁca-
tion, segmentation, labeling, and hybridization with the arrays
were performed according to the manufacturer's standard pro-
tocols (Affymetrix Inc, Santa Clara, CA, USA). The results were
analyzed using Chromosome Analysis Suite software. For the
interpretation of the data, the following public databases were
used: database of genomic variants (DGV; http://projects.tcag.ca/
variation/), Database of Chromosomal Imbalance and Phenotype
in Humans Using Ensembl Resources (DECIPHER; http://decipher.
sanger.ac.uk/), Online Mendelian Inheritance in Man (OMIM;
http://www.omim.org), and University of California Santa Cruz
(UCSC; http://genome.ucsc.edu/, hg19). Conﬁrmation of the copy
number variations (CNVs) identiﬁed was performed by real-time
polymerase chain reaction.
Results
The CMA of Fetus 1 revealed a de novo 1.56-Mb duplication at
17q12 containing 15 OMIM genes (chromosome position:
34822465-36378678, UCSC hg19). Fetus 2 had a de novo 1.93-Mb
deletion at 17q12 encompassing 21 OMIM genes (chromosome
position: 34477479-36404104). Neither the duplication nor dele-
tionwas inherited from the parents. Fig.1 shows the duplicated and
deleted regions and the involved genes in the two fetuses. We
offered detailed genetic counseling to the couples and informed
them of the variable phenotypes of the 17q12 microdeletion/
microduplication syndrome. Ultimately, both couples chose to
terminate the pregnancies.
Discussion
We present our ﬁndings on the prenatal diagnosis of a 17q12
duplication in a fetus with cerebral ventriculomegaly and agenesis
of the corpus callosum and of a 17q12 deletion in a fetus with
R. Li et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 579e582 581multicystic renal dysplasia and PLSVC. To our knowledge, this is the
ﬁrst report of the prenatal diagnosis of a 17q12 duplication in a
fetus with brain abnormalities.
HNF1B and LHX1 are the genes chieﬂy responsible for the
phenotypic features associated with microdeletion and micro-
duplication syndrome, both of which are important for renal and
brain development [1e3,6]. Renal cysts and diabetes are the most
common clinical features of HNF1B anomalies (including 17q12
deletion or HNF1B mutation) [14]. In our study, Fetus 2 had the
typical phenotype of cystic renal disease, as well as enlarged
kidneys and polyhydramnios. Similar ﬁndings have been reported
in previous studies. Decramer et al [1] identiﬁed a 17q12 deletion
in 15/62 (24%) patients with fetal hyperechogenic or cystic kid-
neys; the kidney size was normal in most patients and the am-
niotic ﬂuid was normal in all. Nagamani et al [3] reported three
patients with 17q12 deletions whose prenatal histories recorded
cystic renal disease on ultrasound, and one of the patients addi-
tionally showed oligohydramnios [3]. Dixit et al [4] reported two
children with this microdeletion whose prenatal ultrasound scan
revealed renal cyst and normal amniotic ﬂuid volume. Hendrix
et al [9] reported the prenatal diagnosis of a fetus with a 17q12
deletion remarkable for echogenic and enlarged kidneys, dia-
phragmatic hernia, and cystic left lung on prenatal ultrasound. We
noticed that the amniotic ﬂuid volume and kidney size were var-
iable in the above cases, which indicated the absence of a geno-
typeephenotype correlation between the microdeletion and the
amniotic ﬂuid volume or the kidney size in prenatal cases. These
results, along with our data, suggest that 17q12 deletion analysis
by CMAmay be considered in the setting of prenatal identiﬁcation
of renal hyperechogenicity or cysts, regardless of the kidney size
or the amniotic ﬂuid volume.
Additionally, Fetus 2 manifested PLSVC, which is the most
common thoracic venous anomaly [15]. PLSVC in isolation is
considered benign, but is very frequently associated with other
congenital anomalies, especially cardiac abnormalities [16]. Thus
far, there is only one patient with a cardiovascular defect (atrial
septal defect) reported who was diagnosed with a duplication of
17q12 [11]. These results indicate that some genes in the deleted
or duplicated region may be associated with cardiovascular
development. Barbacci et al [17] concluded that the complex
syndrome associated with HNF1B mutations arises from either
defective DNA binding or decreased transactivation function
through impaired coactivator recruitment. The impaired trans-
activation function of HNF1B could be related to a defective
interaction with these coactivator proteins including CREBBP [17],
which is a transcriptional coactivator and responsible for the
Rubinstein-Taybi syndrome usually involved in congenital heart
defects [18]. We hypothesized that HNF1B may contribute to the
cardiac phenotype by interaction with CREBBP. In this region,
there are two other genes, GGNBP2 and AATF, with a strong
expression in human heart tissue, although it is not currently
known if they contribute to the cardiac abnormality. Another
possibility is that the deletion or duplication has a positional effect
on the function of a gene in the adjacent region.
A duplication of 17q12 was identiﬁed in Fetus 1, who had brain
abnormalities including mild ventriculomegaly, microcephaly, and
agenesis of the corpus callosum on prenatal ultrasound and MRI.
LHX1 is the main gene essential for normal brain development and
function in this chromosomal region. LHX1 is expressed in human
brain tissue, and it is required for the migration of motor axons to
the limbs [19]. LHX1 knockout mice exhibit anencephaly [20].
Previous studies have reported brain abnormalities in postnatal
cases with 17q12 duplications as well as deletions. Mefford et al [2]
reported two patients with 17q12 duplications who exhibited focal
cortical dysplasia on brain imaging. Nagamani et al [3] reportednine patients with chromosome 17q12 rearrangements. Of the ﬁve
patients with a 17q12 duplication, the frontal-occipital circumfer-
ence (FOC) of Patient 8 measured below the 2nd centile (brain
imaging not analyzed). Of the four patients with a 17q12 deletion,
Patients 3 and 4 manifested both renal disease and brain structural
defects. An MRI of the brain revealed that Patient 3 had hyper-
intensities in the hippocampi, and Patient 4 had mild cerebral at-
rophy, substantial atrophy in the left hippocampus, and nonspeciﬁc
ﬁndings of increased FLAIR (ﬂuid-attenuated inversion-re-covery)
intensities in the subcortical white matter of the left superior
frontal gyrus. Bierhals et al [10] reported a child with this micro-
duplication whose FOC was less than the 3rd centile (between 3
and 4 standard deviation), and an MRI of the brain showed per-
iventricular leukomalacia. The above results and our data demon-
strated that 17q12 duplication and deletion analysis by CMA could
be considered in the setting of prenatal identiﬁcation of structural
defects of the brain.
Incomplete penetrance and variable expressivity have been
described for several genomic disorders, including 17q12 dele-
tion and duplication syndromes. Mefford et al [2] reported a
patient with intellectual disability who inherited a 1.5-Mb
duplication of 17q12 from the mother, who had epilepsy. Men-
carelli et al [11] reported a patient with sex reversal, Peters'
anomaly, microphthalmia, glaucoma, cleft soft palate, atrial
septal defect, and severe intellectual disability, who inherited a
17q12 duplication from the unaffected father. Moreno-De-Luca
et al [6] identiﬁed a child with delayed development and
autistic features, who inherited a 1.4-Mb deletion of 17q12 from
his affected mother, who had bipolar disorder, diabetes, and a
kidney cyst. George et al [21] detected a recurrent transmission
of 17q12 deletion in a family with variable phenotypes. The
proband was a girl with attention deﬁcit, hyperactivity, disrup-
tive behavior, and learning difﬁculties. Her brother had mild
developmental delay and bilateral renal cystic disease. Both
children inherited a 17q12 deletion from their mother, who had
learning difﬁculties. Bierhals et al [10] reported a child with
developmental delay, seizures, microcephaly, hypotonia, unusual
stereotypical movements, and changes in the white matter who
inherited a 17q12 tandem 1.4-Mb duplication from his healthy
father. Chen et al [13] reported the prenatal diagnosis of a fetus
with hydronephrosis, hydroureter, and multicystic kidney, who
inherited a 1.75-Mb deletion at 17q12 from the unaffected
mother. Rosenfeld et al [22] estimated that the penetrance for
17q12 deletion and duplication is 34.4% and 21.1%, respectively,
in postnatal patients. The incomplete penetrance and variable
expressivity of the microdeletion and microduplication syn-
dromes pose challenges for counseling regarding prenatal di-
agnoses, especially for the syndrome associated with
neurodevelopmental phenotypes that cannot be ascertained
prenatally. Therefore, in the prenatal genetic counseling session,
comprehensive and detailed information about the estimates for
penetrance and the range of possible phenotypic outcomes of the
syndrome should be offered to the prospective parents. In the
present study, because both fetuses manifested deﬁnite struc-
tural abnormalities on ultrasound, the couples ultimately chose
to terminate the pregnancies.
In summary, we reported the prenatal diagnosis of a 17q12
duplication in a fetus with brain abnormalities and a 17q12
deletion in a fetus with cystic renal disease and PLSVC. Combined
with imaging examination, the application of CMA will improve
the diagnosis of submicroscopic chromosomal aberrations in fe-
tuses with congenital anomalies. The incomplete penetrance and
variable expressivity of the genomic disorder should be
explained in great detail when offering prenatal genetic
counseling.
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